These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34169437)

  • 1. Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment.
    Chawla U; Kashyap MK; Husain A
    Mol Cell Biochem; 2021 Nov; 476(11):3911-3922. PubMed ID: 34169437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
    Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics.
    Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R
    Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
    Gęca T; Wojtowicz K; Guzik P; Góra T
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytochemicals for the treatment of COVID-19.
    Españo E; Kim J; Lee K; Kim JK
    J Microbiol; 2021 Nov; 59(11):959-977. PubMed ID: 34724178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
    Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
    Pietrobon AJ; Teixeira FME; Sato MN
    Front Immunol; 2020; 11():579220. PubMed ID: 33193377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
    Sargiacomo C; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 Mar; 12(8):6511-6517. PubMed ID: 32229706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell.
    Ibrahim S; Monaco GSF; Sims EK
    Islets; 2021 Jul; 13(3-4):66-79. PubMed ID: 33970787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes and COVID-19 infection].
    Kosinski C; Zanchi A; Wojtusciszyn A
    Rev Med Suisse; 2020 May; 16(692):939-943. PubMed ID: 32374541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in the COVID-19 pandemic era.
    Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
    Stoian AP; Catrinoiu D; Rizzo M; Ceriello A
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3379. PubMed ID: 32592507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.